Compounds > gefitinib
Page last updated: 2024-09-03

gefitinib and Hyperplasia

gefitinib has been researched along with Hyperplasia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, C; Liu, M; Liu, S; Long, J; Tan, W; Tang, F; Yang, J; Zeng, O1
Kwon, MJ; Lee, KB; Lee, MY; Lee, SH; Lee, YM; Nguyen, MP; Park, GH1
Cheng, NS; Li, FY; Ma, WJ; Mao, H; Shrestha, A; Yang, Q; Zhang, W; Zhou, Y1
Calabrò, E; De Marinis, F; Fabbri, A; Marchianò, A; Novello, S; Orsenigo, M; Pastorino, U; Sozzi, G; Tamborini, E1
Akizawa, T; Hatamura, I; Negi, S; Orita, H; Saji, F; Sakaguchi, T; Shibata, M; Shiizaki, K1

Other Studies

5 other study(ies) available for gefitinib and Hyperplasia

ArticleYear
Gefitinib-coated balloon inhibits the excessive hyperplasia of intima after vascular injuries through PI3K/AKT pathway.
    Technology and health care : official journal of the European Society for Engineering and Medicine, 2019, Volume: 27, Issue:S1

    Topics: Angioplasty, Balloon, Coronary; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carotid Artery Injuries; Coated Materials, Biocompatible; Gefitinib; Hyperplasia; Paclitaxel; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Vascular System Injuries

2019
Silencing of reversion-inducing cysteine-rich protein with Kazal motifs stimulates hyperplastic phenotypes through activation of epidermal growth factor receptor and hypoxia-inducible factor-2α.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Hypoxia; Colony-Forming Units Assay; ErbB Receptors; Gefitinib; Gene Expression Regulation; Gene Knockdown Techniques; GPI-Linked Proteins; Hyperplasia; Mice; Mice, Nude; Phenotype; Quinazolines; RNA, Small Interfering

2013
Effects of epidermal growth factor receptor inhibitor on proliferative cholangitis in hepatolithiasis.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2015, Volume: 14, Issue:5

    Topics: Adult; Aged; Bile Ducts; Cholangitis; Collagen Type I; Endoscopy, Digestive System; Epithelium; ErbB Receptors; Female; Gefitinib; Gene Expression; Glucuronidase; Humans; Hyperplasia; Ki-67 Antigen; Lithiasis; Liver Diseases; Male; Middle Aged; Mucin-3; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Quinazolines

2015
Prolonged remission of disseminated atypical adenomatous hyperplasia under gefitinib.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:2

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Agents; ErbB Receptors; Female; Gefitinib; Humans; Hyperplasia; Lung; Lung Neoplasms; Middle Aged; Mutation; Polymerase Chain Reaction; Quinazolines; Remission Induction; Tomography, X-Ray Computed

2009
[Enhanced expression of EGFR, TGF-alpha, EGF in hyperplastic parathyroid glands in established stage of renal failure in rats].
    Clinical calcium, 2005, Volume: 15 Suppl 1

    Topics: Animals; Cell Proliferation; Disease Models, Animal; Epidermal Growth Factor; ErbB Receptors; Gefitinib; Hyperplasia; Intracellular Signaling Peptides and Proteins; Male; Parathyroid Glands; Parathyroid Hormone; Phosphorus, Dietary; Quinazolines; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Time Factors; Transforming Growth Factor alpha

2005